HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juan Carlos Gomez Selected Research

LY 2140023

12/2014A Double-Blind, Placebo-Controlled Comparator Study of LY2140023 monohydrate in patients with schizophrenia.
11/2013Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juan Carlos Gomez Research Topics

Disease

4Schizophrenia (Dementia Praecox)
02/2016 - 05/2011
1Parkinson Disease (Parkinson's Disease)
05/2019
1Tremor (Tremors)
05/2019
1Seizures (Absence Seizure)
12/2014
1Vomiting
11/2013
1Chronic Disease (Chronic Diseases)
05/2011

Drug/Important Bio-Agent (IBA)

3pomaglumetad methionilIBA
02/2016 - 11/2013
2LY 2140023IBA
12/2014 - 11/2013
2Quetiapine Fumarate (Seroquel)FDA Link
11/2013 - 05/2011
2Olanzapine (Zyprexa)FDA Link
11/2013 - 05/2011
2Risperidone (Risperdal Consta)FDA LinkGeneric
11/2013 - 05/2011
2Antipsychotic Agents (Antipsychotics)IBA
11/2013 - 05/2011
2Aripiprazole (Abilify)FDA Link
11/2013 - 05/2011
1Serotonin (5 Hydroxytryptamine)IBA
02/2016
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
02/2016
1Glutamic Acid (Glutamate)FDA Link
12/2014
1metabotropic glutamate receptor 2IBA
11/2013
1ziprasidone (Geodon)FDA Link
05/2011
1Haloperidol (Haldol)FDA LinkGeneric
05/2011

Therapy/Procedure

2Therapeutics
05/2019 - 11/2013